Blogbeiträge | Gen Re

Unsere Perspektive

Changes in Cancer Classification - How Do They Impact Critical Illness Insurance?

Von Tim Eppert |July 14, 2020|English

What is a cancer - and what is not? While the answer to this question is obvious in many cases, it is not always straightforward. A disease is deemed as malignant or cancerous when there is an uncontrolled growth of cells that is invasive, i.e., the...
Lesen Sie mehr
World Cancer Day - Celebrating a Decline in U.S. Cancer Mortality

Von Jean-Marc Fix |February 04, 2020|English

When the Cancer Statistics, 2020 report was released a few weeks ago, the press rightfully basked in the great news: In the U.S. there were 2.9 million fewer cancer deaths than there would have been if the historically increasing cancer rates had remained...
Lesen Sie mehr
When Is a Heart Attack a Heart Attack?

Von Dr. John O'Brien |November 05, 2019|English

Right up until the 1960s no specific treatment for heart attack existed; patients were simply advised to go home and rest in bed. Today, although our understanding and treatment of what’s technically called myocardial infarction (MI) has come...
Lesen Sie mehr
Chronic Myeloid Leukaemia - From Fatal to Chronic Disease

Von Dr. John O'Brien |October 16, 2019|English

Major advances in the treatment of chronic myeloid leukaemia (CML) have produced a welcome improvement in its prognosis. CML used to be a universally fatal condition; now, for some patients, it can be considered a chronic illness with little impact...
Lesen Sie mehr
New Methods of Treating Prostate Cancer

Von Dr. Sandra Mitic |July 23, 2019|English | Deutsch

With around 60,000 new cases per year, prostate cancer is the most common type of cancer in men in Germany. The incidence of prostate cancer - especially the early stages - has been increasing steadily for years. This is also due to early detection...
Lesen Sie mehr
2018 U.S. Critical Illness Insurance Market Study Shows Continued Strong Growth

Von Steve Rowley|September 11, 2018|English

Gen Re has just completed our 17th annual U.S. Critical Illness Insurance Market Survey, and we are pleased to announce that the industry continued to grow steadily and profitably. Seventy‐five carriers participated in this year’s survey. Of those,...
Lesen Sie mehr